Vishria Bird Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$381K Buy
1,644
+102
+7% +$20.8K 0.07% 79
2025
Q2
$286K Hold
1,542
0.1% 81
2025
Q1
$323K Hold
1,542
0.11% 69
2024
Q4
$274K Buy
1,542
+30
+2% +$5.52K 0.1% 72
2024
Q3
$299K Hold
1,512
0.11% 70
2024
Q2
$259K Buy
1,512
+7
+0.5% +$1.16K 0.11% 58
2024
Q1
$274K Hold
1,505
0.12% 57
2023
Q4
$233K Hold
1,505
0.11% 56
2023
Q3
$224K Hold
1,505
0.13% 53
2023
Q2
$203K Hold
1,505
0.12% 54
2023
Q1
$240K Hold
1,505
0.15% 50
2022
Q4
$243K Hold
1,505
0.17% 54
2022
Q3
$202K Hold
1,505
0.14% 53
2022
Q2
$231K Hold
1,505
0.15% 53
2022
Q1
$244K Hold
1,505
0.13% 55
2021
Q4
$204K Buy
+1,505
New +$178K 0.09% 64

Other funds holding ABBV

Vishria Bird Financial Group's ABBV Position: Q3 2025 in Review

Vishria Bird Financial Group increased its AbbVie (ABBV) stake by 6.6% in Q3 2025, buying an estimated $20.8K and bringing the position to 1,644 shares worth $381K. The position accounts for 0.07% of the portfolio, ranked #79.

Vishria Bird Financial Group first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Vishria Bird Financial Group held 1,644 shares of AbbVie worth $381K as of Q3 2025.
  • Vishria Bird Financial Group bought 102 AbbVie shares in Q3 2025, an estimated $20.8K.
  • AbbVie made up 0.07% of Vishria Bird Financial Group's portfolio in Q3 2025, its #79 holding.
  • Vishria Bird Financial Group first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Vishria Bird Financial Group's 13F filing for Q3 2025, filed 21 Oct 2025.